Citigroup’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.83K Sell
17,754
-31,458
-64% -$49.4K ﹤0.01% 5220
2025
Q4
$153K Buy
49,212
+19,197
+64% +$54.8K ﹤0.01% 4119
2025
Q3
$78.9K Sell
30,015
-37,419
-55% -$82.5K ﹤0.01% 4346
2025
Q2
$82.9K Buy
67,434
+56,756
+532% +$61.9K ﹤0.01% 4502
2025
Q1
$11.7K Buy
10,678
+10,675
+355,833% +$12.3K ﹤0.01% 5168
2024
Q4
$3 Sell
3
-657,835
-100% -$564K ﹤0.01% 5793
2024
Q3
$649K Buy
657,838
+157,835
+32% +$152K ﹤0.01% 3564
2024
Q2
$450K Sell
500,003
-1,787,777
-78% -$1.34M ﹤0.01% 3465
2024
Q1
$2.7M Buy
2,287,780
+582,344
+34% +$641K ﹤0.01% 2186
2023
Q4
$1.56M Buy
1,705,436
+1,508,704
+767% +$1.11M ﹤0.01% 2456
2023
Q3
$164K Buy
196,732
+194,768
+9,917% +$224K ﹤0.01% 3755
2023
Q2
$2.36K Buy
1,964
+564
+40% +$702 ﹤0.01% 5268
2023
Q1
$1.76K Sell
1,400
-1,204,145
-100% -$2.3M ﹤0.01% 5105
2022
Q4
$2.62M Buy
1,205,545
+130,448
+12% +$1.07M ﹤0.01% 1847
2022
Q3
$12.9M Buy
1,075,097
+200,311
+23% +$2.49M 0.02% 1014
2022
Q2
$7.32M Buy
874,786
+808,377
+1,217% +$6.26M 0.01% 1309
2022
Q1
$576K Sell
66,409
-86,376
-57% -$833K ﹤0.01% 3414
2021
Q4
$1.73M Sell
152,785
-31,993
-17% -$380K ﹤0.01% 2741
2021
Q3
$2.32M Buy
184,778
+6,660
+4% +$61.3K ﹤0.01% 2417
2021
Q2
$1.45M Sell
178,118
-39,515
-18% -$343K ﹤0.01% 2939
2021
Q1
$2.01M Buy
217,633
+200,077
+1,140% +$2.02M ﹤0.01% 2480
2020
Q4
$170K Buy
17,556
+10,889
+163% +$107K ﹤0.01% 5111
2020
Q3
$83K Sell
6,667
-29,959
-82% -$397K ﹤0.01% 5254
2020
Q2
$476K Buy
36,626
+1,068
+3% +$13.4K ﹤0.01% 4308
2020
Q1
$361K Sell
35,558
-3,278
-8% -$42.8K ﹤0.01% 4186
2019
Q4
$607K Buy
38,836
+36,845
+1,851% +$742K ﹤0.01% 4250
2019
Q3
$33K Sell
1,991
-4,288
-68% -$85.3K ﹤0.01% 6401
2019
Q2
$140K Buy
6,279
+3,218
+105% +$61.6K ﹤0.01% 5568
2019
Q1
$66K Buy
+3,061
New +$63.8K ﹤0.01% 6105

Other funds holding GOSS